Odey Asset Management Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Odey Asset Management Group’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-11,430	Closed	-$2.2M	–	72
2018 Q3	$2.2M	Hold	11,430	–	–	0.19%	43
2018 Q2	$1.94M	Hold	11,430	–	–	0.18%	40
2018 Q1	$1.86M	Hold	11,430	–	–	0.2%	42
2017 Q4	$1.71M	Sell	11,430 -834	-7%	-$123K	0.16%	43
2017 Q3	$1.86M	Hold	12,264	–	–	0.17%	47
2017 Q2	$1.58M	Buy	+12,264	New	+$1.48M	0.17%	42

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Odey Asset Management Group's VRTX Position: Q4 2018 in Review

Odey Asset Management Group sold out of Vertex Pharmaceuticals (VRTX) in Q4 2018, closing a stake of 11,430 shares — an estimated $2.2M sold.

Odey Asset Management Group first reported a position in VRTX in Q2 2017 and held it in 6 quarters. The position peaked at $2.2M in Q3 2018. 705 funds tracked by Wall St. Rank hold VRTX as of Q4 2018.

Odey Asset Management Group reported no remaining Vertex Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Odey Asset Management Group sold 11,430 Vertex Pharmaceuticals shares in Q4 2018, an estimated $2.2M.
Odey Asset Management Group first reported a position in Vertex Pharmaceuticals in Q2 2017 and held it in 6 quarters.
Odey Asset Management Group's Vertex Pharmaceuticals position peaked at $2.2M in Q3 2018.
705 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2018.

Based on Odey Asset Management Group's 13F filing for Q4 2018, filed 14 Feb 2019.